In particular, high titers of anti-GAD65 antibodies (> 10,000 IU/mL) are a specific marker for SPS but may also be associated with other neurological disorders such as cerebellar ataxia, epilepsy, and limbic encephalitis (1, 18). This evidence concerns the gene GAD2 and epilepsy.